Effect of combined citicoline and glutamate antibodies on acute, generalized convusions induced by pentylenetetrazol in mice
Abstract
Aim. To study the effectivity of a combination of citicoline, a nootropic substance with neuroregenerative, neuroprotective, and anticonvulsant actions, and glutamate antibodies (АB) with an anticonvulsant action in two models of acute generalized convulsions (AGC) caused by the convulsant pentylenetetrazole (PTZ). Methods. Experiments were conducted on C57Bl/6 mice (n=87) weighing 22-28 g. Effects of combined citicoline and glutamate АB were studied on two models of AGС. In the first series of experiments, AGС was induced by intravenous infusion of a 1% PTZ solution at 0.01 ml/sec. In the second series, AGС was induced by a subcutaneous injection of PTZ 85 mg/kg. To evaluate efficacy of the drug combination minimum intraperitoneal anticonvulsant doses of citicoline (Tserakson, Nicomed Ferrer Internacional, S.A.) and glutamate АB were determined. To this purpose, citicoline was administered at 500 and 300 mg/kg 1 h prior to PTZ, and glutamate АB was administered at 5 and 2.5 mg/kg 90 min prior to PTZ. Glutamate АB was obtained by hyperimmunization of rabbits with a respective conjugated antigen. In the second series of experiments, AGС was induced by a subcutaneous injection of PTZ 85 mg/kg. To evaluate the effect of the drug combination, the drugs were administered at the minimum effective doses determined in the first series of experiment. Control animals were injected with the same volume of saline in the same experimental conditions. Results. The combination of citicoline and glutamate AB used at minimum effective doses of 300 and 2.5 mg/kg, respectively, did not increase the seizure activity in the brain and enhanced anticonvulsant properties of the drugs in two models of AGС. Conclusion. The combination of citicoline and glutamate AT at minimum effective doses did not increase the convulsive activity in the brain, which supported safety of the drug combination. Besides, this study can serve as an experimental justification for using the drug combination in convulsions to favorably influence cognitive functions and slow progression of neurodegenerative processes.
Downloads
References
2. Meador K.J., Loring D.W., Moore E.E. et al. Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults. Neurology. 1995; 45(8): 1494-9.
3. Sung-Pa P., Soon-Hak K. Cognitive Effects of Antiepileptic Drugs. J. Clin. Neurol. 2008; 4: 99-106.
4. Karpova M.N., Kuznecova L.V., Zin'kovskij K.A., Klishina N.Yu. Increase of the seizure threshold in C57BL/6 mice after citicoline administration. Bulleten eksperimentalnoy biologii i meditsiny. 2014; 158(9): 296-8. (in Russian)
5. Karpova M.N., Zin'kovskij K.A., Kuznecova L.V., Klishina N.Yu. Anticonvulsant effects of combined treatment with citicoline and valproate on the model of acute generalized convulsions induced by pentylenetetrazole in wistar rats. Bulleten eksperimentalnoy biologii i meditsiny. 2015; 160(10): 425-8. (in Russian)
6. Kuznecova L.V., Karpova M.N., Zin'kovskij K.A., Klishina N.Ju. Anticonvulsant effects of combined treatment with citicoline and diazepam at their combined application on model of the acute generalized convulsions induced by pentylenetetrazole in Wistar rats. Patologicheskaya Fiziologiya I eksperimentalnaya terapiya. 2016; 60(4): 20-3. (in Russian)
7. Kuznecova L.V., Karpova M.N., Zin'kovskij K.A., Klishina N.Yu. Effect of citicoline on the development of chronic epileptization of the brain (pentylenetetrazole kindling) and acute seizures reaction of kindled mice C57Bl/6]. Patologicheskaya Fiziologiya i Eksperimental`naya terapiya. 2014; 58(3): 4-8. (in Russian)
8. Kravchenko E.V., Ponteleeva I.V., Trofimov S.S. et al. The original nootropic and neuroprotective drug noopept potentiates the anticonvulsant activity of valproate in mice. Eksper. i klin. farmakol. 2009; 72(6): 15-7. (in Russian)
9. Adibhatla R.M., Hatcher J.F. Citicoline decreases phospholipase A2 stimulation and hydroxyl radical generation in transient cerebral ischemia. J. Neurosci. Res. 2003; 73(3): 308-15.
10. Álvarez-Sabín J., Román G. C. The Role of Citicoline in Neuroprotection and Neurorepair in Ischemic Stroke. Brain Sci. 2013; 3(3): 1395-414.
11. Hurtado O., Lizasoain I., Moro M.Á. Neuroprotection and recovery: recent data at the bench on citicoline. Stroke. 2011; 42(Suppl. 1.): 33-5.
12. Hurtado O., Moro M. A., Cardenas A. et al. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport. Neurobiol. Dis. 2005; 18(2): 336–45.
13. Saver J.L. Citicoline: update on a promising and widely available agent for neuroprotection and neurorepair. Rev. Neurol. Dis. 2008; 5(4): 167–77.
14. Secades J. J. Probably role of citicoline in stroke rehabilitation: review of literature. Rev. Neurol. 2012; 54(3): 173-9.
15. Kuznecova L.V., Vetrilje L.A., Karpova M.N. Neuroimmunological aspects of the pathogenesis of epilepsy. Uspehi fiziologicheskih nauk. 2014; 45(3): 3-22. (in Russian)
16. Evseev V.A., Karpova M.N., Vetrilje L.A., Klishina N.Ju., Kuznecova L.V., Trekova N.A. Antibodies to glutamate in systemic administration increase the thresholds of convulsive reaction to pentylenetetrazole. Bulleten eksperimentalnoy biologii i meditsiny. 2005; 140(9): 276-8. (in Russian)
17. Karpova M.N., Vetrilje L.A., Klishina N.Ju., Trekova N.A., Kuznecova L.V., Evseev V.A. Elevation of corazol-induced seizure threshold after active immunization of mice of various genetic strains with glutamate-bovine serum albumin conjugate. Bulleten eksperimentalnoy biologii i meditsiny. 2003; 136 (9): 287-9. (in Russian)
18. Karpova M.N., Vetrilje L.A., Kuznecova L.V., Klishina N.Ju. Increasing the thresholds of convulsive reaction after active immunization glutamate-BSA conjugates in mice and at systemic administration of antibodies to glutamate. Patogenez. 2011; 9(1): 21-6. (in Russian)
19. Karpova M.N., Vetrilje L.A., Kuznecova L.V., Klishina N.Ju., Trekova N.A. Effect of systemic treatment with antibodies against glutamate on the seizure response of C57Bl/6 mice after pentylenetetrazole kindling. Bulleten eksperimentalnoy biologii i meditsiny. 2007; 143(6): 611-3. (in Russian)
20. Karpova M.N., Kuznecova L.V., Vetrilje L.A., Klishina N.Ju. Elevation of seizure threshold after intranasal administration of anti-glutamate antibodies to C57BL/6 mice. Bulleten eksperimentalnoy biologii i meditsiny. 2013; 155(3): 282-5. (in Russian)
21. Kuznecova L.V., Karpova M.N., Vetrilje L.A., Klishina N.Ju. Effects of antibodies to glutamate on focal penicillin-induced epileptic activity. Bulleten eksperimentalnoy biologii i meditsiny. 2013; 155(5): 555-8.
